The Chemours Company is a specialty chemicals business based in the US. The Chemours Company shares (CC) are listed on the NYSE and all prices are listed in US Dollars. The Chemours Company employs 6,500 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in The Chemours Company
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
The Chemours Company stock price (NYSE: CC)Use our graph to track the performance of CC stocks over time.
The Chemours Company shares at a glance
|Latest market close||$35.93|
|52-week range||$17.89 - $37.95|
|50-day moving average||$34.05|
|200-day moving average||$30.50|
|Wall St. target price||$40.36|
|Dividend yield||$1 (3.04%)|
|Earnings per share (TTM)||$1.29|
Buy The Chemours Company shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy The Chemours Company stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
The Chemours Company price performance over time
|1 week (2021-07-20)||N/A|
|1 month (2021-07-01)||1.33%|
|3 months (2021-04-30)||18.97%|
|6 months (2021-01-27)||N/A|
|1 year (2020-07-27)||N/A|
|2 years (2019-07-27)||N/A|
|3 years (2018-07-27)||N/A|
|5 years (2016-07-27)||N/A|
Is The Chemours Company under- or over-valued?
Valuing The Chemours Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Chemours Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Chemours Company's P/E ratio
The Chemours Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, The Chemours Company shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
The Chemours Company's PEG ratio
The Chemours Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 8.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Chemours Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Chemours Company's EBITDA
The Chemours Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $786 million.
The EBITDA is a measure of a The Chemours Company's overall financial performance and is widely used to measure a its profitability.
The Chemours Company financials
|Revenue TTM||$5.1 billion|
|Operating margin TTM||9.06%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||4.09%|
|Return on equity TTM||28.42%|
|Market capitalisation||$5.7 billion|
TTM: trailing 12 months
Shorting The Chemours Company shares
There are currently 7.4 million The Chemours Company shares held short by investors – that's known as The Chemours Company's "short interest". This figure is 3% down from 7.6 million last month.
There are a few different ways that this level of interest in shorting The Chemours Company shares can be evaluated.
The Chemours Company's "short interest ratio" (SIR)
The Chemours Company's "short interest ratio" (SIR) is the quantity of The Chemours Company shares currently shorted divided by the average quantity of The Chemours Company shares traded daily (recently around 1.3 million). The Chemours Company's SIR currently stands at 5.85. In other words for every 100,000 The Chemours Company shares traded daily on the market, roughly 5850 shares are currently held short.
However The Chemours Company's short interest can also be evaluated against the total number of The Chemours Company shares, or, against the total number of tradable The Chemours Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Chemours Company's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 The Chemours Company shares in existence, roughly 40 shares are currently held short) or 0.0479% of the tradable shares (for every 100,000 tradable The Chemours Company shares, roughly 48 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against The Chemours Company.
Find out more about how you can short The Chemours Company stock.
The Chemours Company share dividends
Dividend payout ratio: 55.56% of net profits
Recently The Chemours Company has paid out, on average, around 55.56% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.07% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Chemours Company shareholders could enjoy a 3.07% return on their shares, in the form of dividend payments. In The Chemours Company's case, that would currently equate to about $1 per share.
The Chemours Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The Chemours Company's most recent dividend payout was on 14 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 May 2021 (the "ex-dividend date").
The Chemours Company share price volatility
Over the last 12 months, The Chemours Company's shares have ranged in value from as little as $17.8944 up to $37.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Chemours Company's is 2.1099. This would suggest that The Chemours Company's shares are significantly more volatile than the average for this exchange and represent a higher risk.
The Chemours Company overview
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications. The Thermal & Specialized Solutions segment offers of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment provides polymers and advanced materials. Its Chemical Solutions segment offers industrial chemicals used in gold production, industrial, and consumer applications. The company sells its products through direct channels, as well as through a network of resellers and distributors.
Stocks similar to The Chemours Company
The Chemours Company in the news
Chemours' (CC) Q2 Earnings and Revenues Surpass Estimates
The Chemours Company (CC) CEO Mark Vergnano on Q2 2021 Results - Earnings Call Transcript
The Chemours Company 2021 Q2 - Results - Earnings Call Presentation
Frequently asked questionsWhat percentage of The Chemours Company is owned by insiders or institutions?
Currently 0.96% of The Chemours Company shares are held by insiders and 76.749% by institutions. How many people work for The Chemours Company?
Latest data suggests 6,500 work at The Chemours Company. When does the fiscal year end for The Chemours Company?
The Chemours Company's fiscal year ends in December. Where is The Chemours Company based?
The Chemours Company's address is: 1007 Market Street, Wilmington, DE, United States, 19899 What is The Chemours Company's ISIN number?
The Chemours Company's international securities identification number is: US1638511089 What is The Chemours Company's CUSIP number?
The Chemours Company's Committee on Uniform Securities Identification Procedures number is: 163851108
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert